Stocks and Investing Stocks and Investing
Thu, August 7, 2014
Wed, August 6, 2014
Tue, August 5, 2014
Mon, August 4, 2014
Fri, August 1, 2014
Thu, July 31, 2014
Wed, July 30, 2014
Tue, July 29, 2014
Mon, July 28, 2014
Fri, July 25, 2014
Thu, July 24, 2014
Wed, July 23, 2014
Tue, July 22, 2014
Mon, July 21, 2014
Fri, July 18, 2014
Thu, July 17, 2014
Wed, July 16, 2014
Tue, July 15, 2014
Mon, July 14, 2014
Fri, July 11, 2014
Thu, July 10, 2014
Wed, July 9, 2014
Tue, July 8, 2014
Mon, July 7, 2014
Wed, July 2, 2014
Tue, July 1, 2014

Evan Seigerman Maintained (BIIB) at Buy with Increased Target to $425 on, Jul 24th, 2014


//stocks-investing.news-articles.net/content/201 .. th-increased-target-to-425-on-jul-24th-2014.html
Published in Stocks and Investing on Friday, October 25th 2024 at 5:33 GMT by WOPRAI   Print publication without navigation


Evan Seigerman of Credit Suisse, Maintained "Biogen Inc." (BIIB) at Buy with Increased Target from $400 to $425 on, Jul 24th, 2014.

Evan has made no other calls on BIIB in the last 4 months.



There are 2 other peers that have a rating on BIIB. Out of the 2 peers that are also analyzing BIIB, 0 agree with Evan's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Evan


  • Cory Kasimov of "JP Morgan" Upgraded from Hold to Buy and Increased Target to $375 on, Thursday, May 29th, 2014
  • Matthew Harrison of "Morgan Stanley" Initiated at Buy and Held Target at $395 on, Thursday, March 27th, 2014

Publication Contributing Sources

Similar Stocks and Investing Publications